Patients taking antiretroviral therapy. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy4

CD4-Positive T-Lymphocytes Plasma CD8-Positive T-Lymphocytes Leukocytes, Mononuclear

Organisms4

HIV-1 HIV Proviruses HIV-2

Diseases31

HIV Infections Acquired Immunodeficiency Syndrome AIDS-Related Opportunistic Infections HIV-Associated Lipodystrophy Syndrome HIV Seropositivity Immune Reconstitution Inflammatory Syndrome Viremia Pregnancy Complications, Infectious AIDS Dementia Complex Coinfection Lymphoma, AIDS-Related Cytomegalovirus Retinitis Disease Progression Lipodystrophy Tuberculosis HIV Wasting Syndrome AIDS-Associated Nephropathy Acidosis, Lactic Sarcoma, Kaposi Substance Abuse, Intravenous Hepatitis C Meningitis, Cryptococcal Toxoplasmosis, Cerebral Pneumonia, Pneumocystis Simian Acquired Immunodeficiency Syndrome Leukoencephalopathy, Progressive Multifocal Nocturnal Enuresis Dyslipidemias Tuberculosis, Pulmonary Drug-Induced Liver Injury Chronic Disease

Chemicals and Drugs48

Anti-HIV Agents Anti-Retroviral Agents Reverse Transcriptase Inhibitors HIV Protease Inhibitors RNA, Viral Stavudine Zidovudine Nevirapine Benzoxazines Ritonavir Lopinavir Lamivudine Organophosphonates Indinavir Adenine Pyrimidinones Didanosine Nelfinavir HIV Reverse Transcriptase Dideoxynucleosides Oxazines HIV Protease Antitubercular Agents Saquinavir Antiviral Agents pol Gene Products, Human Immunodeficiency Virus Anti-Inflammatory Agents, Non-Steroidal Aspirin DNA, Viral Pyrrolidinones Biological Markers Drug Combinations Warfarin Protease Inhibitors Trimethoprim-Sulfamethoxazole Combination Placebos Phenytoin Anticonvulsants Risperidone HIV Integrase Inhibitors Cyclohexanes HIV Fusion Inhibitors Antipsychotic Agents Drugs, Generic Receptors, CCR5 Anticoagulants Proton Pump Inhibitors Pyridines

Analytical, Diagnostic and Therapeutic Techniques and Equipment47

CD4 Lymphocyte Count Antiretroviral Therapy, Highly Active Viral Load Drug Therapy, Combination Cohort Studies Treatment Outcome Treatment Failure Drug Administration Schedule Drug Monitoring Lost to Follow-Up Prospective Studies Retrospective Studies Risk Factors Directly Observed Therapy Follow-Up Studies Cross-Sectional Studies Prevalence Incidence Double-Blind Method Multivariate Analysis Longitudinal Studies CD4-CD8 Ratio Proportional Hazards Models Logistic Models Withholding Treatment Lymphocyte Count Clinical Trials as Topic Case-Control Studies Pilot Projects Chemoprevention Survival Analysis Administration, Oral International Normalized Ratio Questionnaires Placebos Statistics, Nonparametric Kaplan-Meier Estimate Randomized Controlled Trials as Topic Odds Ratio Life Expectancy Risk Assessment Regression Analysis Severity of Illness Index Lymphocyte Activation Confidence Intervals Epidemiologic Methods Linear Models

Psychiatry and Psychology8

Medication Adherence Patient Compliance AIDS Dementia Complex Treatment Refusal Substance Abuse, Intravenous Nocturnal Enuresis Homosexuality, Male Sexual Behavior

Phenomena and Processes21

CD4 Lymphocyte Count Viral Load Drug Resistance, Viral Drug Resistance, Multiple, Viral Time Factors Drug Interactions Virus Replication CD4-CD8 Ratio Pregnancy Genotype Lymphocyte Count HIV Seronegativity Virus Latency Viral Tropism Mutation Genes, pol Odds Ratio Dose-Response Relationship, Drug Virus Shedding Homosexuality, Male Lymphocyte Activation

Anthropology, Education, Sociology and Social Phenomena3

Developing Countries Treatment Refusal Socioeconomic Factors

Information Science4

Prevalence Incidence Questionnaires Life Expectancy

Named Groups3

HIV Long-Term Survivors Infant, Newborn Drug Users

Health Care48

Medication Adherence Cohort Studies Patient Compliance Treatment Outcome Infectious Disease Transmission, Vertical Treatment Failure Prospective Studies Retrospective Studies Risk Factors Follow-Up Studies Cross-Sectional Studies Prevalence Incidence Double-Blind Method Multivariate Analysis Longitudinal Studies Treatment Refusal Proportional Hazards Models Logistic Models Withholding Treatment Clinical Trials as Topic Health Services Accessibility Case-Control Studies Drug Costs Pilot Projects Survival Analysis Health Resources Age Factors Questionnaires Ambulatory Care Facilities Statistics, Nonparametric Rural Population Kaplan-Meier Estimate World Health Organization Randomized Controlled Trials as Topic Odds Ratio Life Expectancy Sex Factors Cost-Benefit Analysis Risk Assessment Regression Analysis Socioeconomic Factors Severity of Illness Index Epidemics Comorbidity Confidence Intervals Epidemiologic Methods Linear Models

Geographicals25

South Africa Uganda Botswana Malawi Zambia Africa South of the Sahara Cote d'Ivoire Africa, Southern Zimbabwe Haiti Cameroon United States Thailand Kenya Lesotho Rwanda Cambodia British Columbia Brazil Tanzania India Mozambique Africa San Francisco Ethiopia

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Anthropology, Education, Sociology and Social Phenomena Information Science Named Groups Health Care Geographicals

Anti-HIV Agents HIV Infections CD4 Lymphocyte Count Antiretroviral Therapy, Highly Active Anti-Retroviral Agents Viral Load HIV-1 Reverse Transcriptase Inhibitors HIV Acquired Immunodeficiency Syndrome Drug Resistance, Viral HIV Protease Inhibitors AIDS-Related Opportunistic Infections Drug Therapy, Combination Medication Adherence South Africa RNA, Viral Cohort Studies Stavudine Zidovudine Nevirapine Patient Compliance Benzoxazines Treatment Outcome Infectious Disease Transmission, Vertical HIV-Associated Lipodystrophy Syndrome Ritonavir HIV Seropositivity Immune Reconstitution Inflammatory Syndrome Uganda Viremia Lopinavir Lamivudine Organophosphonates Treatment Failure CD4-Positive T-Lymphocytes Drug Administration Schedule Drug Monitoring Pregnancy Complications, Infectious Indinavir Lost to Follow-Up Prospective Studies Drug Resistance, Multiple, Viral AIDS Dementia Complex Retrospective Studies Risk Factors Botswana Malawi Adenine Time Factors Pyrimidinones Didanosine Coinfection Lymphoma, AIDS-Related Nelfinavir Directly Observed Therapy HIV Reverse Transcriptase Follow-Up Studies Cross-Sectional Studies Drug Interactions Zambia Africa South of the Sahara Dideoxynucleosides Cote d'Ivoire Cytomegalovirus Retinitis Africa, Southern Prevalence Disease Progression Incidence Lipodystrophy Oxazines Tuberculosis HIV Wasting Syndrome HIV Protease Double-Blind Method Antitubercular Agents Developing Countries Zimbabwe Plasma Virus Replication Multivariate Analysis AIDS-Associated Nephropathy Longitudinal Studies CD4-CD8 Ratio Saquinavir Pregnancy HIV Long-Term Survivors CD8-Positive T-Lymphocytes Haiti Cameroon Genotype United States Treatment Refusal Proportional Hazards Models Antiviral Agents Logistic Models pol Gene Products, Human Immunodeficiency Virus Acidosis, Lactic Thailand Withholding Treatment

No FAQ available that match "patients taking antiretroviral therapy"